Q1 2024 Allogene Therapeutics Inc Earnings Call Transcript
Hello, and welcome to the Allogene Therapeutics first quarter 2024 conference call. (Operator Instructions) Please be aware that today's conference is being recorded. We ask that you limit yourself to one question only.
I would now like to turn the conference over to Christine Cassiano, Chief Corporate Affairs and Brand Strategy Officer. You may begin.
Thank you, operator, and welcome to all who have joined this call after the market closed today, Allogene issued a press release that provides a business update and financial results for the first quarter of 2024. This press release and today's webcast are both available on our website. Following our prepared remarks, we will host a Q&A session. We ask you to limit your questions to one per person as we will keep this call to an hour and do our best to get to as many questions as possible.
Joining me today are Dr. David Chang, President and Chief Executive Officer; Dr. Zachary Roberts,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |